Tamami Kiyono Selected Research

pyroglutamylleucine

1/2015	pyroGlu-Leu inhibits the induction of inducible nitric oxide synthase in interleukin-1β-stimulated primary cultured rat hepatocytes.
11/2013	Identification of pyroglutamyl peptides in Japanese rice wine (sake): presence of hepatoprotective pyroGlu-Leu.
9/2013	Ingestion of low dose pyroglutamyl leucine improves dextran sulfate sodium-induced colitis and intestinal microbiota in mice.
7/2013	Identification of a hepatoprotective peptide in wheat gluten hydrolysate against D-galactosamine-induced acute hepatitis in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tamami Kiyono Research Topics

Disease

2	Hepatitis 11/2013 - 07/2013
2	Colitis 11/2013 - 09/2013
2	Body Weight (Weight, Body) 07/2013 - 05/2012
1	Inflammation (Inflammations) 01/2015
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2015
1	Hepatocellular Carcinoma (Hepatoma) 08/2014

Drug/Important Bio-Agent (IBA)

4	pyroglutamylleucineIBA 01/2015 - 07/2013
3	Peptides (Polypeptides)IBA 01/2015 - 05/2012
3	Leucine (L-Leucine)FDA Link 01/2015 - 07/2013
2	Glutens (Glutelin)IBA 01/2015 - 07/2013
1	CytokinesIBA 01/2015
1	Active Hexose Correlated CompoundIBA 08/2014
1	Dextran SulfateIBA 09/2013
1	GalactosamineIBA 07/2013
1	Alanine (L-Alanine)FDA Link 07/2013
1	Transaminases (Aminotransferases)IBA 07/2013
1	Aspartic Acid (Aspartate)FDA Link 07/2013
1	AmpholineIBA 07/2013
1	ElastinIBA 05/2012

Therapy/Procedure

1	Oral Administration 09/2013